0001209191-17-019697.txt : 20170309
0001209191-17-019697.hdr.sgml : 20170309
20170309180310
ACCESSION NUMBER: 0001209191-17-019697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170307
FILED AS OF DATE: 20170309
DATE AS OF CHANGE: 20170309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUVASIVE INC
CENTRAL INDEX KEY: 0001142596
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330768598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 909-1800
MAIL ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hannon Jason
CENTRAL INDEX KEY: 0001330401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50744
FILM NUMBER: 17679711
MAIL ADDRESS:
STREET 1: 7475 LUSK BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-07
0
0001142596
NUVASIVE INC
NUVA
0001330401
Hannon Jason
7475 LUSK BLVD
SAN DIEGO
CA
92121
0
1
0
0
President and COO
Common Stock
2017-03-07
4
M
0
97375
34.82
A
142336
D
Common Stock
2017-03-07
4
F
0
72535
74.63
D
69801
D
Common Stock
2017-03-08
4
S
0
24340
74.21
D
45461
D
Common Stock
2017-03-08
4
S
0
500
74.80
D
44961
D
Employee Stock Option (Right to Buy)
34.82
2017-03-07
4
M
0
97375
0.00
D
2019-01-02
Common Stock
97375
0
D
Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.
Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
Weighted average sales price from sales transactions ranging from $73.71 to $74.70. Upon request by the Commission staff or a security holder
of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each
separate price.
Weighted average sales price from sales transactions ranging from $74.74 to $74.91. Upon request by the Commission staff or a security holder
of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each
separate price.
The option, representing a right to purchase a total of 97,375 shares, was granted on January 2, 2009 and is fully vested.
/s/ Nathaniel B. Sisitsky, Attorney-in-Fact for Jason M. Hannon
2017-03-09